Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF study.

Heinz LudwigPere GascónCarsten BokemeyerMatti AaproMario BoccadoroKris DenhaerynckAndriy KrendyukovKaren MacDonaldIvo Abraham

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)

This real-world evidence indicates that CIN/FN prophylaxis initiated with biosimilar filgrastim within 24-72 h post-chemotherapy is effective and safe. Filgrastim administration on the day of chemotherapy may be appropriate in some patients.

Keyphrases

chemotherapy induced
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
clinical practice
type diabetes
skeletal muscle
adipose tissue
locally advanced